Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Immunohistochemistry [4]
Submit
Validation data
Reference
Comment
Report error
- Product number
- LS-A1205 - Provider product page
- Provider
- LSBio
- Product name
- PathPlus™ GLP1R / GLP-1 Receptor Antibody (N-Terminus) LS-A1205
- Antibody type
- Polyclonal
- Description
- Immunoaffinity purified
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Storage
- Aliquot and store undiluted at -20°C or below for up to 1 year. Can be stored undiluted at 4°C for up to 1 month. Avoid freeze-thaw cycles.
Submitted references Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice.
Glucagon-like peptide-1 modulates neurally evoked mucosal chloride secretion in guinea pig small intestine in vitro.
Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice.
Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4.
GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice.
Lamont BJ, Li Y, Kwan E, Brown TJ, Gaisano H, Drucker DJ
The Journal of clinical investigation 2012 Jan;122(1):388-402
The Journal of clinical investigation 2012 Jan;122(1):388-402
Glucagon-like peptide-1 modulates neurally evoked mucosal chloride secretion in guinea pig small intestine in vitro.
Baldassano S, Wang GD, Mulè F, Wood JD
American journal of physiology. Gastrointestinal and liver physiology 2012 Feb 1;302(3):G352-8
American journal of physiology. Gastrointestinal and liver physiology 2012 Feb 1;302(3):G352-8
Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice.
Himeno T, Kamiya H, Naruse K, Harada N, Ozaki N, Seino Y, Shibata T, Kondo M, Kato J, Okawa T, Fukami A, Hamada Y, Inagaki N, Seino Y, Drucker DJ, Oiso Y, Nakamura J
Diabetes 2011 Sep;60(9):2397-406
Diabetes 2011 Sep;60(9):2397-406
Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4.
Arakawa M, Mita T, Azuma K, Ebato C, Goto H, Nomiyama T, Fujitani Y, Hirose T, Kawamori R, Watada H
Diabetes 2010 Apr;59(4):1030-7
Diabetes 2010 Apr;59(4):1030-7
GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice.
Noyan-Ashraf MH, Momen MA, Ban K, Sadi AM, Zhou YQ, Riazi AM, Baggio LL, Henkelman RM, Husain M, Drucker DJ
Diabetes 2009 Apr;58(4):975-83
Diabetes 2009 Apr;58(4):975-83
No comments: Submit comment
Enhanced validation
- Submitted by
- LSBio (provider)
- Enhanced method
- Genetic validation
- Main image
- Experimental details
- Human Pancreas: Formalin-Fixed, Paraffin-Embedded (FFPE)
- Submitted by
- LSBio (provider)
- Enhanced method
- Genetic validation
- Main image
- Experimental details
- Adrenal
- Submitted by
- LSBio (provider)
- Enhanced method
- Genetic validation
- Main image
- Experimental details
- Brain, Cortex, Neurons
- Submitted by
- LSBio (provider)
- Enhanced method
- Genetic validation
- Main image
- Experimental details
- Lung, small cell carcinoma